Please login to the form below

Not currently logged in
Email:
Password:

rare diseases

This page shows the latest rare diseases news and features for those working in and with pharma, biotech and healthcare.

bluebird bio aiming to separate business units by year-end

bluebird bio aiming to separate business units by year-end

At the beginning of the year, bluebird bio announced plans to spin out its oncology business into a new company, while it remained focused on developing gene therapies for rare diseases.

Latest news

More from news
Approximately 128 fully matching, plus 280 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 16 fully matching, plus 107 partially matching documents found.

Latest appointments

  • Azafaros expands executive team with three senior hires Azafaros expands executive team with three senior hires

    While at Sanofi, she served as head of rare diseases, Central and Eastern Europe – in this role, she led all commercial activities for rare disease-related programmes in those regions.

  • Porter Novelli adds Amber Tovey to London health team Porter Novelli adds Amber Tovey to London health team

    In her new role at Porter Novelli, Tovey will work across a global pharmaceutical client portfolio that includes neurology, rare diseases and HIV.

  • New hires at Crescendo, Healx and Galecto New hires at Crescendo, Healx and Galecto

    Hall (pictured left) has over 25 years of experience in drug development, with the last decade spent focused on rare diseases. ... He co-founded the rare disease patient group support charity Findacure with Nick Sireau, the advisor to and the inspiration

  • New hires at bluebird bio, BioNTech and Provention Bio New hires at bluebird bio, BioNTech and Provention Bio

    Jason's extensive commercial experience, including the planning, preparation and execution of product launches in rare diseases and nascent markets, will be critical as we work to bring teplizumab to type

  • New hires at FibroGen, Saniona and Turbine New hires at FibroGen, Saniona and Turbine

    Saniona . Saniona, a clinical stage biotech focused on rare diseases related to eating disorders and the central nervous system, has appointed Rami Levin (pictured below, right) as chief executive officer. ... He is a veteran biotech leader, with over

More from appointments
Approximately 1 fully matching, plus 59 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 22 fully matching, plus 97 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
ROAD

ROAD is a digital PR and communications consultancy specialising in promoting the innovators that shape our future health and wellbeing....

Latest intelligence

How can we strike the right balance between familiarity and innovation when it comes to data presentation?
Following our webinar in March, Getting MedComms right: navigating the age of the amateur expert, we’re taking the time to respond to questions we were unable to answer during the...
Deep 6 AI: the smart software breathing new life into clinical trials
Fishawack Health interviews Wout Brusselaers, the Deep 6 AI CEO using artificial intelligence to solve one of the greatest barriers stagnating healthcare innovation—clinical trial recruitment and retention....
COVID-proof: How Teams are Creating Launch Intensity thru Adversity
Now that the game has changed, how are marketers shifting their launch behaviour? We've identified 5 common observations from effective teams....